# FDA Inspection 1200677 - Southern Biologics, Inc. - March 03, 2023

Source: https://www.keypedia.com/records/fda_inspections/southern-biologics-inc/edbfcfe4-afe7-424b-bb92-d20b53c4f4a0
Source feed: FDA_Inspections

> FDA Inspection 1200677 for Southern Biologics, Inc. on March 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200677
- Company Name: Southern Biologics, Inc.
- Inspection Date: 2023-03-03
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1200677 - 2023-03-03](https://www.keypedia.com/records/fda_inspections/southern-biologics-inc/3aec487f-7206-4c22-a4b2-1f25432643e4)
- [FDA Inspection 1053160 - 2018-04-27](https://www.keypedia.com/records/fda_inspections/southern-biologics-inc/b65e7eeb-3100-4cbb-abf8-60d02318a763)
- [FDA Inspection 761458 - 2012-01-04](https://www.keypedia.com/records/fda_inspections/southern-biologics-inc/3b549892-bf71-468e-a1d2-fb1811820e1a)
- [FDA Inspection 624467 - 2009-10-30](https://www.keypedia.com/records/fda_inspections/southern-biologics-inc/d8979ce1-86b3-474b-82c1-085a97f64a36)

Company: https://www.keypedia.com/companies/southern-biologics-inc/73984b6d-39df-4924-9f9b-b6ac1c00faf7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d